应用Contour神经血管系统栓塞破裂与未破裂动脉瘤:106例病例总结
本研究回顾性评估106例患者共109个颅内动脉瘤采用Contour神经血管系统(CNS)栓塞治疗的中长期结局,植入成功率为95.5%,6、12、24个月随访时RRS 1级闭塞分别占63.4%、55.5%、70.0%,围手术期总并发症发生率为7.5%。作者认为CNS植入成功率高、中长期稳定性有前景,但需更大规模前瞻性研究验证。
要点
- 植入成功率为95.5%(106例),围手术期总并发症发生率为7.5%(8/106)。
- 6个月随访RRS 1级闭塞为63.4%(44/69),24个月为70.0%(21/30)。
- 择期病例围手术期并发症为5.5%(4/72),动脉瘤破裂病例为11.7%(4/34)。
核心结论
- 作者结论认为CNS植入成功率高、中长期稳定性有前景,6个月早期闭塞的患者24个月后再次干预率低,但需更大规模前瞻性研究验证其在动脉瘤治疗中的作用。
研究设计与样本
- 本研究为遵循STROBE指南的单中心回顾性研究,纳入106例患者共109个颅内动脉瘤,收集人口学、介入数据、动脉瘤特征、手术细节及CNS植入后长达24个月的血管造影随访评估。
诊断标准与关键数值
- 闭塞率以Raymond-Roy分级(RRS)评估:6个月随访106例中69例(65.1%)完成评估,RRS 1为44/69(63.4%)、RRS 2为16/69(23.1%)、RRS 3a为4/69(5.8%)、RRS 3b为5/69(7.2%)。
- 12个月随访106例中44例(41.5%)完成评估,RRS 1为24/44(55.5%)、RRS 2为12/44(27.3%)、RRS 3a为4/44(9.0%)、RRS 3b为4/44(9.0%)。
- 24个月随访106例中30例(28.3%)完成评估,RRS 1为21/30(70.0%)、RRS 2为8/30(26.7%)、RRS 3b为1/30(3.3%)。
临床应用与阅片要点
- 原文报告CNS植入成功率为95.5%,围手术期总并发症为7.5%(8/106),择期病例为5.5%(4/72),动脉瘤破裂病例为11.7%(4/34)。
- 辅助装置使用于13/106例(12.2%)。
- 作者结论指出CNS中长期稳定性有前景,6个月早期闭塞患者24个月后再次干预率低,但需更大规模前瞻性研究验证。
局限性
- 作者在结论中写明需在更大规模前瞻性研究中继续探索以验证CNS在动脉瘤治疗中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Aneurysmal disease of the intracranial vasculature poses a relevant threat, warranting effective interventions. Minimally invasive interventional techniques for aneurysm treatment have evolved to the application of flow-diversion stents and devices. This study focuses on the Contour Neurovascular System (CNS), aiming to add knowledge regarding its mid- to long-term outcomes in treating wide-necked intracranial aneurysms.
MATERIALS AND METHODS: Conducted in accordance with STROBE guidelines, this study retrospectively evaluated all patients with intracranial aneurysms treated with CNS embolization. Demographic and interventional data were collected retrospectively, including aneurysm characteristics, procedural details, and angiographic follow-up evaluations up to 24 months after CNS implantation.
RESULTS: A total of 106 patients with 109 aneurysms were included in this study, whereby 72 patients were treated for an incidental aneurysm, while 34 patients presented with subarachnoid hemorrhage. Implantation was successful in 95.5% of patients. Occlusion rates were as follows: 6 months (69/106, 65.1%): Raymond-Roy-Scale (RRS) 1 44/69 (63.4%), RRS 2 16/69 (23.1%), RRS 3a 4/69 (5.8%), RRS 3b 5/69 (7.2%); 12 months (44/106, 41.5%): RRS 1 24/44 (55.5%), RRS 2 12/44 (27.3%), RRS 3a 4/44 (9.0%), RRS 3b 4/44 (9.0%); 24 months (30/106, 28.3%): RRS 1 21/30 (70.0%), RRS 2 8/30 (26.7%), RRS 3b 1/30 (3.3%). Periprocedural complications: Overall 8/106 (7.5%); elective cases 4/72 (5.5%); aneurysm rupture 4/34 (11.7%). Adjunctive devices were used in 13/106 cases (12.2%).
CONCLUSIONS: The present work reports the long-term angiographic and clinical follow-up results of a single-center cohort of 106 patients with intracranial aneurysms treated with the CNS. The CNS demonstrated a high rate of successful implantation and promising mid- and long-term stability, with a low reintervention rate beyond 24 months in patients exhibiting early occlusion at 6 months. While acknowledging the limitations, these findings contribute valuable information about the safety and efficacy of the CNS, and warrant continued exploration in larger, prospective studies to validate its role in aneurysm treatment.
引用
- Wodarg F, Neves FB, Gärtner F, et al. Embolization of Ruptured and Unruptured Aneurysms with the Contour Neurovascular System-Summary of 106 Cases. AJNR Am J Neuroradiol. 2025. PMID: 40147835. doi:10.3174/ajnr.A8606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。